Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases (Q33804148)

29 July 2017

1 reference

title

Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases (English)

1 reference

29 July 2017

W Chen

1

1 reference

29 July 2017

S M Wahl

series ordinal

2

1 reference

29 July 2017

publication date

1 December 1999

1 reference

29 July 2017

published in

Microbes and Infection

1 reference

29 July 2017

volume

1

1 reference

29 July 2017

issue

15

1 reference

29 July 2017

page(s)

1367-1380

1 reference

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Type beta transforming growth factor: a bifunctional regulator of cellular growth

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Transforming growth factor beta: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

TGF-beta: a balancing act.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Regulation of immune responses by TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

TGFbeta signaling: receptors, transducers, and Mad proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Inflammatory and immunomodulatory roles of TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Transforming growth factor beta: a matter of life and death

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Deactivation of macrophages by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Macrophage Production of TGF-? and Regulation by TGF-?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Organ-specific disease provoked by systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

A gene therapy approach to treatment of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

1 reference

7 January 2021

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Oral administration of schistosome egg antigens and insulin B-chain generates and enhances Th2-type responses in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Peripheral deletion of antigen-reactive T cells in oral tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

In vivo mechanisms of acquired thymic tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Control of immune pathology by regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Peripheral autoantigen induces regulatory T cells that prevent autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Molecular Role of TGF-β, Secreted from a New Type of CD4+Suppressor T cell, NY4.2, in the Prevention of Autoimmune IDDM in NOD Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

CD4+ T-cell subsets in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

The Yin and Yang of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

CTLA-4 ligation blocks CD28-dependent T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Intravenous immunoglobulins and transforming growth factor beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Immunomodulation with linomide: possible novel therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Oral collagen in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900249-X

7 January 2021

10.1016/S1286-4579(99)00249-X

Identifiers

DOI

1 reference

29 July 2017

1 reference